Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction  by Pedretti, Roberto F.E. et al.
JACC V& 23, No. I
January 1994 : 1
9 -26
Effect of Thrombolysis on Heart Rate Variability
Ventricular Arrhythmias in Survivors of Acuite My
Objectives. The aim of the present study was to determine the
influence of early thrombolysis on ventricular tachyarrhydnNs
(clinical and inducible) and heart rate variability in survivors of
myocardial infarction at high risk for life-threatening ventricular
arrhythmias .
Background. A greater electrical heart stability may be impor-
tant in improving survival in patients treated with thrombolysis .
Few data are available about the influence of fibrinelyAs on postin-
farction arrhythmic events and other prognostic variables, such as
inducible ventricular tachycardia and bent rate variability.
Methods. The study group comprised 51 consecutive patients
who underwent electrophysiologic study within 30 days of infare .
[ion, owing to the presence of two or more of the following
criteria : left ventricular ejection fraction <40%, late potentials
and repetitive ventricular ectopic beats. Thirty patients under .
went throanbolysis within 6 h of the onset of symptoms (Group A),
and 21 received conventional treatment (Group B) . Inducibility of
sustained monomorphic ventricular tachycardia was tested in. both
groups, and the standard deviation of all normal RR intervals
during 24-h Holler monitoring was calculated . All patients were
prospectively evaluated for occurrence of arrhythmic events.
It is well known that early fibrinolytic treatment during acute
myocardial infarction reduces subsequent mortality, but it is
unclear whether only improved left ventricular function or
other factors contribute to this favorable effect (1) . An
increased electrical heart stability could have an important
role (1), but the effect of fibrinolytic treatment on postinfarc-
tion arrhythmic events has not yet been defined . Reduced
heart rate variability and inducibility of sustained monomor-
phic ventricular tachycardia at electrophysiologic study
have been found to predict postinfarction arrhythmic events
independently of left ventricular ejection fraction (2-8) . If,
after reperfusion, a change in arrhythmic propensity occurs,
an influence of thrombolytic therapy on both the aforemen-
tioned risk markers may be expected . At present, the
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Results. The two groups were similar with regard to left
ventricular ejection fraction (mean ±
I S1138 ± 6% [Group A] vs .
36 ± 8% [Group B]) . Ventricular tachycardia was induced in 6
(20%) of 30 Group A patients versus 14 (67%) of 21 Group B
patients (p = 0.002) . The standard deviation of normal RR
intervals was higher in Group A than in Group B (113 ± 36 vs .
90 :t 39 ms, p = 0.05) . In patients with anterior infarction, the
standard deviation of normal RR intervals was higher in 19
patients with thrombolysis than in 16 patients with conventional
treatment (118 ± 41 vs. 74 ± 24 ms, p = 0. 2). During a men
follow-up period of 23 ± 11 months, 4 (13%) of 30 Group A
patients had an arrhythmic event versus 9 (43%) of 21 Group B
patients (p = 0.04).
Conclusions . After myocardial infarction, in high risk patients,
thronebolysis significantly reduced the occurrence of arrhythmic
events independently of left ventricular function . This effect may
be related to both an improvement in electrical heart stability, as
elucidated by electrophysiologic study, and a favorable action on
the cardiac sympathovagal balance .
(J Am Cog Cardiol 1994 ;23:19-26)
19
1119
relation between intravenous thrombolysis and heart rate
variability has not yet been investigated, and controversial
data are available about the influence of fibrinolytic treat-
ment on induced ventricular arrhythmias (9-13) . We per-
formed a prospective study of survivors of a recent myocar-
dial infarction at high risk for late arrhythanic events to
assess 1) the influence of thrombolysis on inducibility of
sustained monomorphic ventricular tachycardia at pro-
grammed stimulation, 2) the influence of fibrinolysis on heart
rate variability, 3) the influence of thrombolysis on post-
infarction arrhythmic events, and 4) the hypothesis of an
independent relation between limitation of infarct size and
improvement of electrical heart stability after thrombolytic
therapy .
Methods
Patient selection and study design . In the period from
September 1989 to January 1992, 319 consecutive patients
aged <70 years who survived an acute myocardial infarction
were admitted to our institute within 30 days of the infarction
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PEDRETTI ET AL
.
THROMBOLYSIS AND POSTINFARCTION ARRHYTHMIC EVENTS
for cardiac rehabilitation and underwent a standard risk
stratification protocol to evaluate electrical heart instability
.
It included measurement of left ventricular ejection fraction
by two-dimensional echocardiography, detection of ventric-
ular late potentials by a signal-averaged electrocardiogram
(ECG) and 48-h Holter monitor analysis for ventricular
ectopic beats and heart rate variabilit ; '.'final-averaged
ECG and Hotter monitoring were performed in all patients in
the drug-free state
. The period of washout from digitalis,
beta-adrenergic blocking agents, calcium antagonists and
antiarrhythmic drugs was five or more times the plasma
half-life of the drug . No patient had bundle branch block,
atrial flutter or atrial fibrillation, ventricular paced rhythm,
heart failure, unstable angina, poor echocardiogram, balloon
angioplasty or coronary artery grafting before being admit-
ted to our institute. Lawn class 4a or b ventricular ectopic
beats, late potentials and left ventricular ejection fraction
<40% were defined noninvasive markers of arrhythmic risk .
Those patients who had two or more of these risk factors
were considered at high risk for arrhythmic events and were
eligible for programmed ventricular stimulation after consent
of both patient and attending physician . Of 319 patients, 71
(22%) were eligible for electrophysiologic testing, but pro-
grammed stimulation was performed only in 51 of these
(72%). The 20 other patients, or their attending physicians,
were unwilling to give informed consent. Thus, 51 patients
comprise the study group. Clinical and demographic charac-
teristics of both the study group and the 20 patients who
refused to participate in the investigation are listed in Table
L The study protocol was approved by the committee on
human investigation at our institution .
All patients had follow-up contact by phone . A late
arrhythmic event was defined as sudden death or the occur-
rence of symptomatic or sustained ventricular arrhythmia
>5 days after infarction . Sudden death was defined as a
witnessed, unexpected death occurring within 1 h of the
onset of symptoms or during sleep. Sustained ventricular
arrhythmia was defined as spontaneous ventricular fibrilla-
tion or tachycardia lasting >30 s or necessitating cardiover-
sion because of hemodynamic collapse .
On hospital discharge, neither beta-blockers nor other
antiarrhythmie drugs were prescribed routinely to patients
with or without inducible ventricular tachycardia or high
grade ventricular ectopic activity .
Thrombolsytic therapy. The decision to treat a patient
with a thrombolytic agent was made by the attending physi-
cian in the coronary care unit. Of 51 patients included in the
study, 30 (59%) received intravenous thrombolysis (strep-
tokinase 11 .5 million U for 60 min) or recombinant tissue-
type plasminogen activator [100 mg for 180 min]), and 21
(41%) were treated conventionally because of late hospital
admission or contraindications to fibrinolytic treatment .
Thrombolytic therapy was initiated within 6 h of the onset of
symptoms. The mean time from symptom onset to initiation
of thrombolysis was 110 ± 67 min .
Table 1
. Clinical and Demographic Characte tics of Tested and
Excluded Patients
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*Median and lower and upper quartiles. Other values presented are mean
value ± I SD or number (l) of patients . AMI = acute myocardial infarction ;
LAS 40 = duration of low-amplitude signals <40 AV ; LVEF = left ventricular
ejection fraction ; QRS = duration of filtered QRS complex
; RMS 40 =
root-mean-square voltage of last 40 ms of filtered QRS complex
; SDNN =
standard deviation of normal RR intervals : VF = ventricular fibrillation
;
VPCs = ventricular premature complexes ; VT = ventricular tachycardia .
Etectrophysiol is study. Programmed ventricular stimu-
lation was performed in the drug-free state 25 ± 8 days after
infarction using a protocol we (8) have previously described .
Up to three extrastimuli were introduced after 8 ventric-
ular paced beats at three drive cycle lengths (600, 500 and
400 ms) in the right ventricular apex . Only the induction of
sustained monomorphic ventricular tachycardia at a rate
<270 beats/min was regarded as a positive result. Polymor-
phic ventricular tachycardia, ventricular fibrillation or un-
sustained arrhythmias were each regarded as nonspecific
responses .
Heart rate variability assessment . Heart rate variability
was computed over the 1st 24-h interval of Holter monitoring
(recorded 21 ± 6 days after infarction) . Each beat was
characterized as normal or aberrant according to its recog-
nition by the algorithm for tape analysis and after human
overreading . Cycles in which beats had normal morphologic
characteristics and cycle lengths within 20%v duration of the
preceding cycle length were measured . Periods with the
highest and the lowest average RR intervals were always
reviewed . To measure heart rate variability we used a
Marquette Electronics software program, and the mean
heart period and standard deviation of all normal RR inter-
vals for 24 h were computed .
Echocardiographic studies . A two-dimensional echo-
cardiogram was obtained using a Ving Med CFM 750 unit
16 ± 6 days after infarction, and evaluation of left ventric-
Tested
(n=51)
Excluded
(n = 20)
p
Value
Age (yr) 58 t7 5±10 .08
Male/female 4714 16/4 0 .20
Previous AMI 10(20) 6(30) 1 .00
VF 0-5 days after AM[ 8(16) 4(20) 100
Anterior AM[ 3509) 1000) 0.23
Q wave AMI 49(96) 16(80) 0 .05
Thrombolysis 3009) 11(55) 0.97
LVEF (%) 37+_7 42±5 0
Late potentials 32(63) 17 (85) 0.12
QRS (ms) 110 ± 13 108 ± 12 0.53
RMS 40 (nV)" 13 .8, 31 13,E, 17 0.88
LAS 40 (ms) 40 ± 12 43 ± 22 0.50
VPCS/h* 2 .5. 0.45, 20.8 1 .0, 0.35, 5 .75 0.37
Paired VPCs 33(63) 1400) 0.88
Unsustained VT 26(51) 8(40) 0.56
Mean RR interval (ms) 801 ± 110 828 ± 75 0.32
SDNN (ms) 103 ± 39 118 ± 27 0 .19
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ular ejection fraction by the Simpson formula was per-
formed .
Other diagnostic procedures. A signal-averaged ECG was
recorded 20 ± 7 days after infarction using a commercially
available system (Fidelity Medical LP 3 )D  whose princi-
ples and operation we (14) have previously described . The
high pass filter was set at 40 Hz . Signals from 203 ± 55 beats
were averaged to achieve a final noise level <0 .5 ;kV . The
normal values of a signal-averaged ECG were defined as
follows : filtered QRS complex duration ~ 114 ms, root-mean-
square voltage of the last 40 ms of the filtered QRS complex
2:20 p.V and duration of terminal low amplitude (<40 gV)
signals {38 ms . Late potentials were considered present if
two or more determinants of the signal-averaged ECG were
abnormal . A 48-h Holler monitor recording 21 ± 6 days after
infarction was analyzed with a Marquette Electronics Holter
8000 T. The following ventricular arrhythmia data were
quantified for each tape : ventricular ectopic beats/h and the
presence of both ventricular couplets and runs of unsus-
tained ventricular tachycardia (run of ~3 consecutive ven-
tricular ectopic beats lasting <30 s) .
Statistical analysis. Continuous variables were tested for
normal distribution with the Kolmogorov-Smirnov goodness-
of-fit test for normality. When a normal distribution was
observed, continuous variables were expressed as mean value
± I SD and compared by using the Student unpaired t test .
When observed frequencies were significantly different from
the expected normal distribution, continuous variables were
expressedd as median and lower and upper quartiles and were
compared by using the nonparametric Mann-Whitney test .
Discrete variables were compared by chi-square analysis with
the Yates correction for continuity or the Fisher exact test . To
assess the relation between heart rate variability and continu-
ous variables, simple linear regression analysis was fitted . In
all statistical tests, a two-tailed p value < 0 .05 was required for
statistical significance . A multifactor analysis of variance was
used to assess the influence of age, left ventricular ejection
fraction and previous infarction on the relation between heart
rate variability and thrombolysis in patients with anterior wall
myocardial infarction . All of these analyses were performed by
the Statgraphics statistical package, version 4 .0. Using the
BMDP LR program (BMDP Statistical Software, 1990), logis-
tic regression analysis was performed to determine which of
five variables (see Appendix) contributed independent informa-
tion to the prediction of both inducibility of sustained mono-
morphic ventricular tachycardia and occurrence of late ar-
rhythmic events during follow-up . The BMDP LIZ program
enters independent variables in a stepwise manner . The step
selections are based on the maximal likelihood ratio . The p
values used for entry and removal of variables were set at 0 .05
and 0.1, respectively . At each step in the stepping process,
log-likelihood, the change in the log-likelihood since the previ-
ous step and evaluations of the model using goodness of fit
chi-square statistics were provided .
21
Resuhs
Study group characteristics . We compared clinical and
demographic characteristics of patients who were or were
not studied in the present investigation . As shown in Table 1,
only left ventricular ejection fraction was significantly differ-
ent (p = 0.008) between the two groups of patients : It was
lower in the study group .
Follow-up data. Follow-up data for all 51 patients were
analyzed . At 23 ± 11 months after infarction, 13 patients
(25%) developed a late arrhythmic event . Sustained ventric-
ular tachycardia occurred in eight patients, sudden death in
two and aborted sudden death with evidence of ventricular
fibrillation at the time of candioversion in three . Of 13 events,
10 (77%) occurred in the 1st 2 months after infarction (mean
29 ± 17 days, range 9 to 55) ; 3 (33%) were observed 6 to 18
months after infarction ; and 9 (69%) occurred during the
hospital period . Follow-up data for 20 excluded patients
were also available . At 29 ± 9 months after infarction, four
(20%) of these patients had an arrhythmic event . Sustained
ventricular tachycardia occurred in two patients, sudden
death in one, and aborted sudden death in one . When
arrhythmic event rate was compared between tested and
nontested patients, no significant difference was found in the
total number of arrhythmic events (13[25%] of 51 vs . 4[20%]
of 20, p = 1 .00) or the occurrence of arrhythmic events
before study selection (4 [31%) of 13 vs . 2 [50%] of 4, p
1 .00) .
Prescription of beta-blacker and antiorrhythnile drug ther-
apy. Most arrhythmic events (9 of 13) occurred during the
hospital period. During this period, patients with and with-
out events were undergoing pharmacologic washout from
antiarrhythmic drugs and beta-blockers . At hospital dis-
charge, empiric antiarrhythmic therapy was administered by
the attending physician to 11 (2691)) of 42 asymptomatic
patients (mexiletine in 5, amiodarone in 6) because of
inducible, sustained ventricular arrhythmias . Two (18%) of
I I patients receiving antiarrhythmic drugs had arrhythmic
events compared with 2 (6%) of 31 without (p = 1 .00). At
hospital discharge, beta-blockers were prescribed in 5 (12%)
of 42 asymptomatic patients owing to residual ischemic
symptoms or hypertension . None of 5 patients with beta-
blockerss developed arrhythmic events compared with 4
(11%) of 37 without (p = 1 .00) .
Comparison of patients with and without inducibility of
sustained monomorphic ventricular tachycardia at pro-
grammed ventricular stimulation . Of 51 patients tested by
programmed ventricular stimulation, 20 (39%) had positive
findings on electrophysiologic study because sustained
monomorphic ventricular tachycardia at a rate <270 beats/
min was inducible
. Of the variables listed in Table 2, the
following had a significant relation to the inducibility of
sustained monomorphic ventricular tachycardia : thrombol-
ysis (p = 0 .002), left ventricular ejection fraction (p = 0 .001)
and filtered QRS complex duration (p = 0 .03) .
22
Table 2
. Characteristics of Patients With and Without Inducible
Sustained Monomorphic Ventricular Tachycardia at Programmed
Ventricular Stimulation
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°Median and lower and upper quartiles. Oilier values presented are mean
value ± I SD or number (%) of patients . Abbreviations as in Table 1 .
Comparison of patients with and without late arrhythmic
events. Of the variables listed in Table 3, the following had
a significant relation to late arrhythmic events : thrombolysis
(p = 0.04), left ventricular ejection fraction (p = 0 .0005) and
the standard deviation of normal RR intervals (p = 0 .03) .
Inducibility of sustained monomorphic ventricular tachycar-
dia at a rate <270 beats/min was strongly related to postin.
Table 3. Characteristics of Patients With and Without
Arrhythmic Events
*Median and lower and upper quartiles
. Other values presented are mean
value ;
I SD or number (%) of patients
. Abbreviations as in Table 1 .
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farction arrhythmic events. Late arrhythmic events occurred
in 12 (60%) of 20 patients with positive, compared with 1
(3%) of 31 with negative findings on electrophysiologic
study (p = 0 .0002). In the group with thrombolysis, time
from symptom onset to initiation of fibrinolysis was signifi-
cantly longer in 4 patients with arrhythmic events than in 26
patients without arrhythmic events (184 ± 94 vs. 97
63 min, p = 0 .02) .
Multivariate analysis . The results of stepwise logistic
regression analysis are shown in Table 4 . Of the five vari-
ables listed in the Appendix, only left ventricular ejection
fraction and thrombolysis were found to be independent
predictors of both inducibility of sustained monomorphic
ventricular tachycardia and occurrence of postinfarction
arrhythmic events .
Comparison of patients with and without thrombolytic
therapy. We compared the characteristics of patients who
received thrombolysis with those of patients treated conven-
tionally . Of the variables listed in Table 5, only filtered QRS
complex duration on the signal-averaged ECG was different
between the two groups of patients . It was significantly (p =
0.02) lower after thrombolysis .
Relations among heart rate variability, thrombolytic ther-
apy and other variables . The standard deviation of all nor-
mal RR intervals for 24 h was higher in patients with
thrombolysis than in conventionally treated patients (113
36 vs . 90 ± 39 ms) ; the statistical analysis showed a
borderline p value (p = 0 .05) (Fig . I). No significant differ-
ence was observed between the two groups of patients with
regard to the mean heart period (818 ± 115 vs . 785 ± 113 ms,
p = 0.30). We evaluated the relation between heart rate
variability and other variables that are known to influence
the sympathovagal interaction after acute myocardial infarc-
lion (15-18). The standard deviation of all normal RR inter-
vals for 24 h had a significant linear relation with both age
(r = -0.42, p = 0.003) and left ventricular ejection fraction
(r = 0.46, p = 0 .001) . Heart rate variability was significantly
lower in 10 patients with a previous infarction than in 41
patients without a previous infarction (80 ± 29 vs . 109 ±
38 ms, p = 0.03). Heart rate variability was not related to
infarct site . No significant difference was found between 35
patients with anterior wall infarction and 16 patients with
inferior wall infarction (100 ± 40 vs . 111 ± 32 ms, p = 0.50).
Because only two patients had a non-Q wave infarction, the
relation between Q wave development and heart rate vari-
ability was not assessed .
Relation between heart rate variability and thrombolysic
therapy in patients with anterior wall myocardial infarction .
Because patients with anterior wall myocardial infarction
and low ejection fraction are known to be at high risk for
arrhythmic events, especially when a left ventricular aneu-
rysm is present (12), we analyzed the influence of thrombol-
ysis on heart rate variability in 35 patients with anterior
infarction. Of these, 18 (51%) had a left ventricular aneu-
rysm, and mean left ventricular ejection fraction was 34 ±
5%. Both standard deviation of all normal RR intervals
Events
(n = 13)
No Events
(n = 38)
p
Value
Age (yr) 60 t 7 58 t 6 0.56
Male/female 12/1 35/3 1 .00
Previous AMI 4(31) 606) 1 .00
VP 0-5 days after AMI ](8) 7 (18) 1 .00
Anterior AM[ 11(85) 24(63) 1 .00
Q wave AMI 12(92) 37 (97) 1 .00
Thrombolysis 401) 2608) 0.04
LVEF (%) 32 ± 7 39 ± 6 0.0005
Late potentiale 8(61) 24(63) 1 .00
QRS (ms) 113 ± 12 109 ± 13 0.28
RMS 40 (iV)* 17.7.41 13, 8 .30 0.60
LAS 40 (ms) 37 ± 15 41 a 11 0.36
VPCsIh* 1 .79, 0 .45 . 14 .1 4.66 .0.8 . 64.77 0.41
Paired VPCs 9(69) 24(63) 1 .00
Unsustained VT 7(54) 19(50) 1 .00
Mean RR interval (ms) 760 ± 83 820 ± 121 0.09
SDNN (ms) 84 ± 33 III ± 38 0.03
Sustained Monomorphic VT at
Programmed Stimulation
Present
(n = 20)
Absent
(n = 31)
p
Value
Age (yr) 61 ± 7 58 t 6
0.13
Malelfemale 19/1
28/3 1 .00
Previous AMI 5(25) 506) 1
.00
VF 0-5 days after AMI 3051 506) 1 .00
Anterior AMI 16(00) 19(61) 0.18
Q wave AMI 19(95) 30(97) 1 .00
Thrombolysis 600)
24(71) 0.002
LVEF (%) 33 t7 39 ± 6 0.001
Late potentials 13(65) 1901) I
.00
QRS (ms) 115 ± 13 107 ± 11 0.03
RMS 40 (KV)° 15, 6, 30 13 .8 .33 0.85
LAS 40 (ms) 40 ± 14 40 :t 11 0.92
VPCs/h* 2 .14.0.43 . 11 .55 6 .67, 1 .04, 72 .08 0.18
Paired VPCs 10(50) 23(74) 0.14
Unsustained VT 11(55) 15(49) 0.86
Mean RR interval (ms) 782 t 109 819 ± 117 0.26
SDNN (ms) 90±36 112 t 38 0.06
JACC Vol
. 23, No . I
January 1994
:19-26
Table 4. Summary of Stepwise Logistic Regression Analysis
Abbreviations as in Table: 1 .
(118 ± 41 vs. 74 ± 24 rns, p 0.0002) (Fig . 2) and mean heart
period (807 ± 83 vs . 739 85 ins, p = 0.04) were signifi-
cantly higher in 19 patients treated with thromholysis than in
16 patients who received conventional therapy . Left ventric-
ular ejection fraction was higher after thrombolysis (36 t 5%
vs. 32 ± 4%) ; statistical analysis showed a borderline p value
(p = 0.05). A multifactor analysis of variance was performed
in patients with anterior infarction to assess the effects of
three covariates (age, left ventricular ejection fraction and
previous infarction) on the relation between thrombolysis
and heart rate variability . After allowing for these possible
influences, heart rate variability was still significantly (p
0.03) related to thromMytic therapy (Table 6) .
Discussion
Thrombollytic therapy and arrhythmugenic propensity af-
ter acute myocardial infarction
. An extremely low mortality
rate was observed in patients with reperfusion compared
with the rate in those without (1) . This finding contrasts
*Median and lower and upper quartiles . Other values presented are mean
value ± I SD or number (%) of patients. Abbreviations as in Table 1 .
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Log of
Likelihood
strikingly with the relatively modest changes in left ventric-
ular function observed between the two groups of patients .
The mechanism responsible for reduced mortality after
fibrinolysis has not yet been examined (19), and previous
studies suggest that improvement in electrical heart stability
could be important in increasing survival in patients after
reperfusion (9,12,13) . The crucial determinant of predispo-
sition to ventricular tachycardia or fibrillation (and sudden
death) is the capacity to sustain ventricular tachycardia or
fibrillation in the presence of an arrhythmogenic substrate
and spontaneous ventricular ectopic beats. Inducibility of
sustained monomorphic ventricular tachycardia, during elec-
trophysiologic study seems to be marker for that datermi-
nai-it (4-8) . If a change in electrophysiologic milieu after
thrombelyfic therapy occurs, a favorable action of reperfu-
sional therapy on inducibility of sustained ventricular tachy-
Figurel
. Effect of thrombol y lie therapy on standard deviation of all
normal RR intervals (SDNN) for 24 h
. The group mean value t I SD
is displayed adjacent to scatter plot data
. Standard deviation of
0
.05) after thrombolysis .
Chi-Square
Improvement
p Value
Chi-square
0
0
0
cd
0
0
Go0,
11uss Of Fit
p Value
THROMBOLYTIC THERAPY
CONVENTIONAL THERAPY
(n = 21)
(r
=:
: 30)
Dependent Variabic : Inducibility of Sustained Monosnorphic VT at Programmed Stimulation
0
-31301 60.603 0 .060
1 LVEF
-25 .655 9.292 U .002 51 .310 Uri
2
Thrombolysis -22
.590
6-131
0
.013 45 .179 0 .381
Dependent Variable : Occurrence of Late Arrhythmic Events
0
-27 .388 54.777 0 .151
I LVEF
1 -20.067
14
.643 0.0m 40.134 0,638
2
Thrombolysis 1 -17.714
4 .705
0.030 35 .429 0.787
normal RR intervals was higher (p
Table 5 . Characteristics of Patients With and Without 2220,
Thrombolytic Therapy
2004
0
Thrombolysis
(n = 30)
No Thrombolysis
(n = 21)
p
Value
180,
Age (yr)
58 ± 6 60 ± 7
0 .45
Malelfemale
2812
1912 1 .00
1604
Previous AM[
4 (13)
6(2 08)
0.28
140
VF 0-5 days after AMI
5 (17)
3 (14)
1 .00
Anterior AM[ 19 (63)
16 (76)
0.36
120
Q wave AMI
29(97) 20(95)
1 .00
00
LVEF (%)
38 ± 6
36 ± 8
0 .31
100-1
Late potentials
1603)
16 (76)
0 .17
QRS (ms)
107 ± 12 115 ± 11
0 .02
804
RMS 40 (AV)*
14, 10,40
13, 7, 17 0 .09
604
LAS 40 (ms)
37 ± 12 43 ± 11
0.07
VPCs/h*
710*01
1.1 0 .4, 14 .1
0.37
W
Paired VPCs
21 (70) 12 (57)
0.51
Unsustained VT
17(57) 9 (43)
0.49
20
Team
Step
Degrees of
No . Entered
Removed Freedom
24
220-
200 .
ISO
so
40
20
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0
THROMBOLYTIC THERAPY CONVENTIONAL THERAPY
(n W19) (n = 16)
Figure 2. Effect of thrombolytic therapy on standard deviation of all
normal RR intervals (SDNN) for 24 h in patients with anterior wall
myocardial infarction . The group mean value ± I SD is displayed
adjacent to scatter plot data . A strong (p = 0.0002) improvement in
standard deviation of normal RR intervals was found in patients
treated with thrombolysis .
arrhythmias may be hypothesized . Controversial data are
available concerning this point . Kersschut et al . (9), Sager et
al. (12) and Bourke et al. (13) found a lower rate of
inducibility after thrombolytic therapy, whereas Treese et al .
(10) did not . Moreover, in the study of McComb et al . (11),
successful reperfusion by thrombolytic agents did not influ-
ence inducibility of sustained ventricular tachycardia . In
patients preselected by noninvasive techniques, with a high
event rate during follow-up, the present investigation
showed that a significantly lower proportion of patients had
inducible, sustained monomorphic ventricular tachycardia
after thrombolysis. Because inducibility of sustained mono-
morphic ventricular tachycardia during electrophysiologic
study strongly predicts the occurrence of arrhythmic events
after myocardial infarction (4-8), the evidence of a lower
inducibility rate in patients treated with thrombolysis could
have clinical relevance .
Table 6 . Results of Multifactor Analysis of Variance
Abbreviations
as in Table 1 .
The signal-averaged EGG allows the noninvasive detec-
tion of late potentials at the end or after the QRS complex
(20) . Late potentials represent low amplitude fractionated
electrical activity and are markers for an arrhythmogenic
substrate that may become the site for reentry (21) and
provide important prognostic information in identifying pa-
tients at risk for arrhythmic events after acute myocardial
infarction (4,8,22-25) . Several studies found a significantly
lower prevalence of late potentials after thrombolysis
(14,26-29) . Moreover, a significant correlation between pa-
tency of the infarct-related coronary artery and reduced
prevalence of late potentials was found (14,26-29), and the
status (patency or occlusion) of the infarct-related artery
appeared to be the strongest independent predictor of late
potentials on the signal-averaged ECG (14,26,28) . In the
present investigation, in a high risk group of patients,
thrombolysis significantly reduced filtered QRS duration, the
most important of the signal-averaged ECG determinants
(8,23,25). This finding could have particular relevance . In
fact, in other reports the relation between signal-averaged
ECG abnormalities and thrombolysis was analyzed in unse-
lected groups of patients (14,26-29) . Our finding may reflect
a lower mass of myocardium with inhomogeneous propaga-
tion of conduction in patients treated with thrombolysis and
is in agreement with the lower prevalence of inducible,
sustained monomorphic ventricular tachycardia . Both of
these results were obtained despite the failure of thrombo-
lytic therapy to significantly improve global left ventricular
function and could be related to the status of the infarct-
related artery .
Thrombolytic therapy and heart rate variability after acute
myocardial infarction . Calculating the standard deviation of
all normal RR intervals, Kleiger et al . (2) found that heart
rate variability was a significant independent predictor of
mortality in the 1st year after acute myocardial infarction .
Some frequency domain measures of heart period variability
were significantly associated with both all-cause mortality
and arrhythmic death (3). At present, the influence of
thrombolytic therapy on autonomic function has not been
widely examined. Casolo et al . (18) have evaluated heart rate
variability during the early phase of myocardial infarction to
study its changes over time and its relation with clinical and
Source of Variation Sum of Squares
Degrees of
Freedom Mean Square
F
Ratio
P
Value
Covariates 14,276 .245
3 4,758 .7482 4.141 0.01
LVEF
6.795 .483 1
6.795 .4828 5.913 0.02
Age (yr) 1,851 .887 1 1,851 .8869
1 .611 0.21
Previous AMI 958
.261 1 958.261 0
.834 0.37
Main effects
6,062 .6799 1
6,062.6799 5.275
0.03
Thrombolysis
6.062.6799 1
6,062 .6799 5.275 0.03
Residual 29.880
.043 26
1,149.2324
Total 50,218.968
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instrumental data available in the coronary care unit . These
investigators pointed out a greater 24-h standard deviation in
patients receiving thrombolytic therapy related to a higher
left ventricular ejection fraction (18) . However, multivariate
analysis was not periorrned . The present investigation
showed a favorable effect of thrombolysis on heart rate
variability, especially in patients with anterior wall infarction
and low left ventricular ejection fraction, who represent a
group with a very high risk for late arrhythmic events (12) .
Moreover, when adjusted for age, ejection fraction and
previous infarction, the standard deviation of all normal RR
intervals was still significantly influenced by thrombolysis .
This previously unreported finding suggests that in patients
with a low left ventricular ejection fraction who are at high
risk for arrhythmic events, thrombelytic therapy could in-
duce an improvement in autonomic function that is in-
dependent of infarct size limitation . Because the autonomic
dysfunction is of primary importance in determining life-
threatening ventricular tachyarrhythmias after myocardial
infarction, our finding may have clinical relevance .
Thromho3yfic therapy and late arrhythmic events after
acute myocardial inFarction . Previous studies (9,12-14,26-
29) and the present investigation showed a significant reduc-
tion in invasive and noninvasive risk markers in patients
receiving thrombolytic therapy, suggesting reduced ventric-
ular electrical instability . After thrombolysis we found a
significantly lower prevalence of arrhythmic events at a
mean follow-up interval of 23 months, This finding is in
agreement with data of Sager et al . (12), who found that early
thrombolytic therapy resulted in improved arrhythmic out-
come in patients with a transmural anterior myocardial
infarction and subsequent left ventricular afleur-,,m forma-
tion. Moreover, in our high risk patients multivariate analy-
sis showed that thrombolytic therapy was a significant
predictor of arrhythmic events, independent of left ventric-
ular ejection fraction . Nevertheless, ejection fraction was
more significant than thrombolysis as a predictor of late
arrhythmic events, probably because the reopening of the
infarct-related coronary artery, not thrombolytic therapy
itself, may exert a protective effect on postinfarction ven-
tricular electrical instability . A recent study strongly sup-
ports this hypothesis (30). Horvitz et al . (30) analyzed the
influence of infarct-related artery patency on appropriate
shock-free survival in 54 patients with a left ventricular
aneurysm and lethal arrhythmias who received an impiant-
able defibrillator. These investigators found a trend toward
improved shock-free survival in the patients with an aneu-
rysm and an open infarct-related artery and suggested a
potential therapeutic role for a patent infarct-related vessel
in subsequent malignant ventricular arrhythmias . We found
that the timing of the administration of thrombolytic agents
influenced the arrhythmic event rate . Therefore, the time
from symptom onset to initiation of thrombolytic therapy
could influence heterogeneity of myocardial injury and the
subsequent development of an arrhythmogenic substrate
(31). Benefit occurred in patients who received therapy
earlier, probably because higher rates of reperfusiorl can be
achieved by early administration of thromboiytic agents
(32) .
Mechanisms of reduction of electrical heart instability by
thrombolytic therapy. Because the structure of the border
zone is a critical determinant of arrhythmogenesis after
myocardial infarction (13), one car, hypothesize that reper-
fusion of the infarct-related coronary artery may cause some
favorable changes in the border zone . Thrombolytic therapy
may reduce ischemia, facilitate focal hemorrhage (33) and
induce alterations in the electrophysiologic characteristics of
the border zone myocardial cells . All of these effects may
suppress slow and inhomogeneous conduction that supports
reentrant ventricular tachyarrhythmias . Moreover, reperfu-
sion may influence the remodeling process (34), making the
establishment of a functional arrhythmic circuit unlikely .
The effect on the remodeling process may be important in
explaining the improvement induced by thrombolysis in
heart rate variability because the remodeling of the left
ventricle may increase the firing of sympathetic afferent
fibers by mechanical distortion of the sensory endings (35) .
Study limitations. We examined a well defined cohort of
patients, and it is possible that our results are not applicable
to other groups of patients, especially those with uncompli-
cated myocardial infarction . This was not a randomized
investigation. Because thrombolysis clearly improves sur-
vival in patients with acute myocardial infarction, particu-
larly those with a larger infarct size, withholding such
therapy for research purposes would be unethical . Coronary
angiography was not available, and this represents an impor-
tant limitation of the study . Results would be strengthened
by the addition of angiographic data concerning patency of
the infarct-related artery .
This was an uncontrolled study . Thus, it is possible that
the use of antiarrhythmic drugs influenced the arrhythmic
event rate . A greater proportion of patients with than with-
out an arrhythmic event were receiving antiarrhythmic drug
therapy, but this difference did not reach statistical signifi-
cance. In the present investigation, beta-blockers were in-
frequently used, probably because most patients had a low
left ventricular ejection fraction . It is impossible at present
to exclude the effects of infrequent use of beta-blockers on
the arrhythmic event rate . However, statistical analysis did
not find a significant difference in event occurrence between
patients with and without beta-blockade .
Of patients suitable for electrophysiologic study, only a
proportion (72 17c) underwent programmed ventricular stimu-
lation. Statistical analysis found that the patients tested were
similar to those excluded for all arrhythmic risk markers
except ejection fraction, which was significantly lower in
patients who consented to undergo the study . The propor-
tion of patients with an arrhythmic event before study
selection was simi!ar between the two groups. Although
arrhythmic event frequency and other prognostic variables
did not influence patient selection, referring physicians or
patients were more likely to accept performance of the study
if a large infarct had occurred . Therefore, doubt must exist
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as to the applicability of these results to our patients, who
were preselected by noninvasive tests, as a whole .
Appendix
Variables Used in Stepwise Logistic
Analysis
Variables used in stepwise logistic regression analysis were those that
reached a p value < 0
.10 at univariate statistical analysis : thrombolytic
therapy
. left ventricular ejection fraction, filtered QRS complex duration
.
standard deviation of all normal RR intervals for 24 h and mean heart period
.
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